CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival
CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival
About this item
Full title
Author / Creator
Wedig, Jessica , Jasani, Shrina , Mukherjee, Debasmita , Lathrop, Hannah , Matreja, Priya , Pfau, Timothy , D’Alesio, Liliana , Guenther, Abigail , Fenn, Lexie , Kaiser, Morgan , Torok, Molly A. , McGue, Jake , Sizemore, Gina M. , Noonan, Anne M. , Dillhoff, Mary E. , Blaser, Bradley W. , Frankel, Timothy L. , Culp, Stacey , Hart, Phil A. , Cruz-Monserrate, Zobeida and Mace, Thomas A.
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Pancreatic cancer is an aggressive disease with a 5 year survival rate of 13%. This poor survival is attributed, in part, to limited and ineffective treatments for patients with metastatic disease, highlighting a need to identify molecular drivers of pancreatic cancer to target for more effective treatment. CD200 is a glycoprotein that interacts wi...
Alternative Titles
Full title
CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival
Authors, Artists and Contributors
Author / Creator
Jasani, Shrina
Mukherjee, Debasmita
Lathrop, Hannah
Matreja, Priya
Pfau, Timothy
D’Alesio, Liliana
Guenther, Abigail
Fenn, Lexie
Kaiser, Morgan
Torok, Molly A.
McGue, Jake
Sizemore, Gina M.
Noonan, Anne M.
Dillhoff, Mary E.
Blaser, Bradley W.
Frankel, Timothy L.
Culp, Stacey
Hart, Phil A.
Cruz-Monserrate, Zobeida
Mace, Thomas A.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3038410922
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3038410922
Other Identifiers
ISSN
1432-0851,0340-7004
E-ISSN
1432-0851
DOI
10.1007/s00262-024-03678-6
